Table A-2.
Costs (2013 US dollars) used in the CVD PREDICT model
| Parameter | Base-case Value | Base-Case Source |
|---|---|---|
| Costs for Chronic Disease States | ||
| Disease Free | $0 | Assumption: None |
| Chronic CHD | $3,201 | Lee 2010 (16) |
| Chronic Stroke | $2,115 | Pignone 2006 (17) |
|
| ||
| Costs for Acute Disease States | ||
| Acute Cardiac Arrest | $19,271 | O’Sullivan 2011 (22) |
| Acute MI | $56,358 | O’Sullivan 2011 (22) |
| Acute Angina | $29,139 | O’Sullivan 2011 (22) |
| Acute Stroke | $19,128 | O’Sullivan 2011 (22) |
|
| ||
| Costs for Procedures and Repeat Events | ||
| Repeat MI | $56,358 | O’Sullivan 2011 (22) |
| Repeat Stroke | $19,128 | O’Sullivan 2011 (22) |
| CABG | $36,872 | O’Sullivan 2011 (22) |
| PTCA | $34,742 | O’Sullivan 2011 (22) |
|
| ||
| Screening Costs | ||
| Non-lab test (GP visit in Stage 1) | $75 | Pletcher 2009 (19) |
| Cholesterol (lab) test | $35 | Pletcher 2009 (19) |
| # extra GP visits during Stage 2 | 1 | Assumption |
| # lab tests/year after treatment | 1 | Lazar 2011 (53), Expert Opinion |
| # GP visits/year after treatment | 1 | Lazar 2011 (53), Expert Opinion |
|
| ||
| Statin Drug and Adverse Event Costs | ||
| Statin | $267 | Redbook 2009 (54) |
| Anti-hypertensive | $206 | Nuckols 2011 (20) |
| Aspirin | $7.6 | Pignone 2006 (17) |
| ACE Inhibitor | $52.12 | Shah 2011 (21), Redbook 2009 (54) |
| Beta Blocker | $52.12 | Shah 2011 (21), Redbook 2009 (54) |
| Mild adverse event | $178.53 | Lee 2010 (16) |
| Major adverse event | $7,033 | Lee 2010 (16) |